FDA approves new Tx for postherpetic neuralgia.(News)
Publication: Skin & Allergy News
Publication Date: 01-FEB-05
Author: Mechcatie, Elizabeth
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
Pregabalin a drug that binds to calcium channels in the central nervous system, was approved by the Food and Drug Administration for the management of pain associated with postherpetic neuralgia in late December 2004.
There are now three FDA-approved treatments for this indication; the others are gabapentin (Neurontin) and the 5% lidocaine patch. The FDA also approved pregabalin for the pain...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
